SSc patients with elevated serum IL-31 levels had higher frequencies of dcSSc, pulmonary fibrosis, and esophagus involvement, all of which are the clinical consequences of fibrosis, when compared to the patients with normal IL-31 levels. Here, IL31 is linked to systemic sclerosis.